Sun17October0644AM 1
In patients with atrial fibrillation (AF):
True / False
When taking warfarin, the international normalised ratio (INR) should be maintained between 2 and 3 Correct
Less than 10% of patients will revert spontaneously to sinus rhythm within one week of onset Correct
Amiodarone should be avoided in those congestive cardiac failure Correct
Antiarrhythmic drugs are successful in converting atrial fibrillation (of less than seven days duration) in less than 10% of patients Correct
Flecainide should be avoided in those with ischaemic heart disease Correct
Explanation
Up to 60% of patients revert to sinus rhythm within a few days of developing AF. Provided pharmacological conversion is attempted within seven days, successful restoration of sinus rhythm can occur in up to 90% of patients.
Flecainide should be avoided in patients with ischaemic heart disease and any evidence of myocardial dysfunction.
Risk of thrombosis can be stratified using the CHA2DS2-VASc score . This system scores points up to a maximum of 9, for each of the following risk factors:
Age <65 0 points
65-74 1 point
=75 2 points
Gender Male 0 points
Female 1 point
Congestive heart failure 1 point
Hypertension 1 point
Stroke, TIA, or thromboembolism 2 points
Vascular disease 1 point
Diabetes mellitus 1 point
A score of 0 indicates low risk, a score of 1 indicates low-to-medium risk and a score of 2 or more indicates moderate-to-high risk. NICE guidelines on atrial fibrillation recommend that people with a CHA2DS2-VASc score of 2 or more should be offered anticoagulation with apixaban, dabigatran etexilate, rivaroxaban, or a vitamin K antagonist.
It should be noted that aspirin monotherapy should not be offered solely for stroke prevention in these people.
Amiodarone should be used in those with evidence of myocardial dysfunction.
Reference:
NICE. Atrial fibrillation: the management of atrial fibrillation (CG180).
Answer Statistics
Not enough data to display the statistics
Average score: 77.52%
Times answered: 266